Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer

Naruto Taira, Masataka Sawaki, Yukari Uemura, Tsuyoshi Saito, Shinichi Baba, Kokoro Kobayashi, Hiroaki Kawashima, Michiko Tsuneizumi, Noriko Sagawa, Hiroko Bando, Masato Takahashi, Miki Yamaguchi, Tsutomu Takashima, Takahiro Nakayama, Masahiro Kashiwaba, Toshiro Mizuno, Yutaka Yamamoto, Hiroji Iwata, Yasuo Ohashi, Hirofumi Mukai, Takuya Kawahara, Unknown

Open source

DOI: 10.1200/jco.20.02751
Published: 2021-08-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.20.02751,
  title = {Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer},
  author = {Naruto Taira and Masataka Sawaki and Yukari Uemura and Tsuyoshi Saito and Shinichi Baba and Kokoro Kobayashi and Hiroaki Kawashima and Michiko Tsuneizumi and Noriko Sagawa and Hiroko Bando and Masato Takahashi and Miki Yamaguchi and Tsutomu Takashima and Takahiro Nakayama and Masahiro Kashiwaba and Toshiro Mizuno and Yutaka Yamamoto and Hiroji Iwata and Yasuo Ohashi and Hirofumi Mukai and Takuya Kawahara and Unknown},
  year = {2021},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.20.02751},
  url = {https://doi.org/10.1200/jco.20.02751}
}

RIS

TY  - JOUR
TI  - Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer
AU  - Naruto Taira
AU  - Masataka Sawaki
AU  - Yukari Uemura
AU  - Tsuyoshi Saito
AU  - Shinichi Baba
AU  - Kokoro Kobayashi
AU  - Hiroaki Kawashima
AU  - Michiko Tsuneizumi
AU  - Noriko Sagawa
AU  - Hiroko Bando
AU  - Masato Takahashi
AU  - Miki Yamaguchi
AU  - Tsutomu Takashima
AU  - Takahiro Nakayama
AU  - Masahiro Kashiwaba
AU  - Toshiro Mizuno
AU  - Yutaka Yamamoto
AU  - Hiroji Iwata
AU  - Yasuo Ohashi
AU  - Hirofumi Mukai
AU  - Takuya Kawahara
AU  - Unknown
PY  - 2021
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.20.02751
UR  - https://doi.org/10.1200/jco.20.02751
ER  -

APA

Taira, N., Sawaki, M., Uemura, Y., Saito, T., Baba, S., Kobayashi, K., Kawashima, H., Tsuneizumi, M., Sagawa, N., Bando, H., Takahashi, M., Yamaguchi, M., Takashima, T., Nakayama, T., Kashiwaba, M., Mizuno, T., Yamamoto, Y., Iwata, H., Ohashi, Y., Mukai, H., Kawahara, T., & Unknown (2021). Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.20.02751

Source records

crossref · retrieved 2026-09-26T02:56:22.294Z